BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20547568)

  • 1. Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.
    Williams BB; Kwakye GF; Wegrzynowicz M; Li D; Aschner M; Erikson KM; Bowman AB
    Toxicol Sci; 2010 Sep; 117(1):169-79. PubMed ID: 20547568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation.
    Kwakye GF; Li D; Bowman AB
    Neurotoxicology; 2011 Oct; 32(5):630-9. PubMed ID: 21238486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.
    Bichell TJV; Wegrzynowicz M; Tipps KG; Bradley EM; Uhouse MA; Bryan M; Horning K; Fisher N; Dudek K; Halbesma T; Umashanker P; Stubbs AD; Holt HK; Kwakye GF; Tidball AM; Colbran RJ; Aschner M; Neely MD; Di Pardo A; Maglione V; Osmand A; Bowman AB
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1596-1604. PubMed ID: 28213125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
    Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.
    Stansfield KH; Bichell TJ; Bowman AB; Guilarte TR
    J Neurochem; 2014 Dec; 131(5):655-66. PubMed ID: 25099302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute manganese treatment restores defective autophagic cargo loading in Huntington's disease cell lines.
    Bryan MR; O'Brien MT; Nordham KD; Rose DIR; Foshage AM; Joshi P; Nitin R; Uhouse MA; Di Pardo A; Zhang Z; Maglione V; Aschner M; Bowman AB
    Hum Mol Genet; 2019 Nov; 28(22):3825-3841. PubMed ID: 31600787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
    Trettel F; Rigamonti D; Hilditch-Maguire P; Wheeler VC; Sharp AH; Persichetti F; Cattaneo E; MacDonald ME
    Hum Mol Genet; 2000 Nov; 9(19):2799-809. PubMed ID: 11092756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.
    Wegrzynowicz M; Holt HK; Friedman DB; Bowman AB
    J Proteome Res; 2012 Feb; 11(2):1118-32. PubMed ID: 22191580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
    Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
    Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter.
    Erikson KM; Aschner M
    Neurotoxicology; 2006 Jan; 27(1):125-30. PubMed ID: 16140386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.
    Bryan MR; Bowman AB
    Adv Neurobiol; 2017; 18():113-142. PubMed ID: 28889265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.
    Tidball AM; Bryan MR; Uhouse MA; Kumar KK; Aboud AA; Feist JE; Ess KC; Neely MD; Aschner M; Bowman AB
    Hum Mol Genet; 2015 Apr; 24(7):1929-44. PubMed ID: 25489053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
    J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms.
    Kwakye GF; Jiménez JA; Thomas MG; Kingsley BA; McIIvin M; Saito MA; Korley EM
    Neurotoxicology; 2019 Jan; 70():48-61. PubMed ID: 30399392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status.
    Kumar KK; Goodwin CR; Uhouse MA; Bornhorst J; Schwerdtle T; Aschner M; McLean JA; Bowman AB
    Metallomics; 2015 Feb; 7(2):363-70. PubMed ID: 25599126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.